Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Ivabradine (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 01 Jan 2014 Results published in the Heart.
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 28 Mar 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.